Clinical Trials Logo

Filter by:
NCT ID: NCT01976195 Withdrawn - Clinical trials for Immune Thrombocytopenia

High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP

Start date: October 2013
Phase: Phase 2
Study type: Interventional

The project was undertaking by Qilu Hospital of Shandong University in China. In order to report the efficacy and safety of thalidomide combining with high-dose dexamethasone for the treatment of adults with primary immune thrombocytopenia (ITP), compared to conventional high-dose dexamethasone mono-therapy.

NCT ID: NCT01936194 Withdrawn - Atopic Dermatitis Clinical Trials

The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic Dermatitis

Start date: September 2013
Phase: N/A
Study type: Interventional

This clinical trial will study the effects of PUFA supplementation during pregnancy and lactation period on fatty acid composition in human milk and plasma of the mothers and the clinical outcome of atopic dermatitis in infants at increased risk.

NCT ID: NCT01930955 Withdrawn - Clinical trials for Acute Upper Respiratory Tract Infection

Non-antibiotic Prescribing for Acute Upper Respiratory Tract Infection

Start date: August 1, 2011
Phase: N/A
Study type: Interventional

Some acute upper respiratory tract infection(AURI) in children is characterized by fever and vomiting,and it is one common reason for visiting a pediatrician. White blood count(WBC) usually increased in this children patients,hence antibiotics are often prescribed properly assumed. In the present study, it was hypothesized that it was not necessary to prescribe amoxicillin for the children.

NCT ID: NCT01890200 Withdrawn - Chronic Hepatitis C Clinical Trials

The Effects of Adding TCM-700C on the Standard Combination Treatment for HCV Genotype 1 Patients(Phase III)

Start date: June 2015
Phase: Phase 3
Study type: Interventional

This is a randomized, double blind, multi-center, placebo controlled, three parallel arms, Phase IIb/III clinical study to evaluate the effects of adding a TCM-700C with a low or high dose onto the combination treatment (PegIFN plus RBV) for subjects with naive genotype 1 HCV infection. This will be demonstrated by a higher sustained virologic response rate, defined as the absence of detectable HCV RNA 24 weeks after the termination of combination treatment, compared with the placebo add-on.

NCT ID: NCT01882127 Withdrawn - Clinical trials for Idiopathic Thrombocytopenic Purpura

All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)

Start date: February 2013
Phase: Phase 3
Study type: Interventional

The project was undertaking by Qilu Hospital of Shandong University in China. In order to report the efficacy and safety of All-Trans Retinoic Acid (ATRA) combining with High-dose Dexamethasone for the treatment of adults with primary immune thrombocytopenia (ITP), compared to conventional high-dose dexamethasone therapy.

NCT ID: NCT01871740 Withdrawn - Hypertension Clinical Trials

CSPPT- Chronic Kidney Diseases Study

CSPPT-CKD
Start date: May 2008
Phase: Phase 4
Study type: Interventional

The purpose of this trial is to confirm that enalapril maleate and folic acid tablets is more effective in preventing renal function decline among the patients with primary hypertension when compared to enalapril maleate.

NCT ID: NCT01869049 Withdrawn - Clinical trials for Immune Thrombocytopenia

The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia

ITP
Start date: November 2012
Phase: N/A
Study type: Observational

This project was undertaken by Qilu Hospital of Shandong University and other well-known hospitals in China. In order to report the alteration on the macrophage function in the spleen tissue of primary immune thrombocytopenia (ITP).

NCT ID: NCT01864512 Withdrawn - Clinical trials for Immune Thrombocytopenia

Alteration of Different Immune Parameters in Immune Thrombocytopenia (ITP) Patients Receiving Eltrombopag Treatment

Start date: March 2013
Phase: N/A
Study type: Observational

This project was undertaken by Qilu Hospital of Shandong University and other well-known hospitals in China. In order to report the alteration of Different Immune Parameters in ITP Patients Receiving Eltrombopag Treatment.

NCT ID: NCT01812135 Withdrawn - Clinical trials for Infection, Viral, Enterovirus

Safety and Immunogenicity of EV71 Vaccine With or Without Aluminum Adjuvant in Infants

Start date: September 2011
Phase: Phase 2
Study type: Interventional

A randomized, double-blind, phase II-02 clinical trial is to evaluate the safety and immunogenicity of an inactivated EV71 vaccine with or without aluminum adjuvant

NCT ID: NCT01796444 Withdrawn - Breast Cancer Clinical Trials

Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node

Z0011-China
Start date: January 2013
Phase: Phase 3
Study type: Interventional

The recently randomized trial (ASCOG Z0011) support that among patients with limited sentinel lymph node (SLN) metastatic breast cancer treated with breast conservation and systemic therapy, the use of sentinel lymph node biopsy (SLNB) alone compared with axillary lymph node dissection (ALND) did not result in inferior survival. These patients, therefore, are unlikely to benefit from further surgery that results in a longer period of hospitalization, higher costs and higher postoperative morbidity. This result has been written in the 2012 National Comprehensive Cancer Network Clinical Practice Guidelines. However, Limitations of Z0011, such as failure to achieve target accrual and possible randomization imbalance favoring the SLNB-alone group, must be considered. In the other hand, further testing in different country are needed. The investigators design and begin a prospective randomized multicenter phase III study of ALND vs. no ALND in breast Cancer with positive SLN--the validation of Z0011 in China.